期刊文献+

黄曲霉毒素诱发大鼠肝细胞癌过程中细胞外调节蛋白激酶信号转导通路的动态变化 被引量:4

Dynamic changes of signal transduction pathway of extracellular signal regulated kinase during hepatocarcinoge-nesis induced by aflatxin B1 in rats
下载PDF
导出
摘要 目的:探讨细胞外信号调节蛋白激酶(extracellular signal regulated kinase,ERK)信号转导通路在肝细胞癌(hepato-cellular carcinoma,HCC)发生、发展过程中的变化及其作用。方法:以SD大鼠为研究对象,随机分为空白对照组和实验组,实验组腹腔注射黄曲霉毒素B1(aflatoxin B1,AFB1),分别于实验第12、20、36和46周进行肝活检,58周时处死大鼠并剖腹获取肝组织及肿瘤组织,对所有标本均进行常规病理组织学检测后,采用RT-PCR和Western印迹法分别检测所获取组织中ERK1和ERK2 mRNA及蛋白的表达。结果:实验组46周时发现首只罹患HCC的大鼠,实验结束时实验组共有30只大鼠存活,其中24只大鼠发生HCC,6只大鼠无任何肿瘤发生;空白对照组11只大鼠均无肿瘤发生。RT-PCR检测发现,发生肿瘤、未发生肿瘤及空白对照组大鼠肝组织在实验不同时期的ERK1和ERK2 mRNA的表达水平无明显差异(P>0.05);但发生肿瘤大鼠的HCC组织ERK1和ERK2 mRNA表达水平较发生肿瘤前各时间点活检肝组织有明显上升(P<0.01),且较癌旁肝组织、同期无癌大鼠及空白对照组大鼠肝组织的表达明显上调(P<0.05)。Western印迹法检测结果发现,HCC组织p-ERK1及p-ERK2蛋白的表达较癌旁肝组织、发生肿瘤前各时期肝组织及无癌大鼠肝组织明显上升(P<0.01)。结论:在HCC发生早期ERK1和ERK2处于相对正常的状态,而在癌变期ERK1和ERK2信号转导通路表现出异常激活状态,提示ERK1和ERK2信号转导通路可能参与了HCC的发生与发展。 Objective:To explore the changes of signal transduction pathway of extracellular signal regulated kinase(ERK1/2) in the initiation and progression of hepatocellular carcinoma(HCC) and their significance.Methods:Totally 77 male SD rats were randomly divided into two groups.The experimental group(n=66 rats) were administered aflatoxin B1(AFB1) by intraperitoneal injection for 32 weeks.Whereas,11 rats were not administered AFB1 and served as control group.All of animals underwent liver biopsy at week 12,week 20,week 36,and week 46 during the experiment.All the surviving rats were sacrificed at week 58 and their livers and/or tumor tissues were isolated.Routine Mayer's hematoxylin and eosin(H&E) staining was performed on all the livers and tumor samples.The mRNA and protein expression levels of ERK1/2 genes were determined by RT-PCR and Western blotting,respectively.Results:The first case of HCC was discovered at week 46.Totally 30 rats survived at the end of the experiment(week 58).Among the AFB1-treated rats 24 rats developed HCC and 6 rats had no carcinoma.No tumor was developed in the control group.RT-PCR showed that there was no significant difference in ERK1 and ERK2 mRNA expression in liver tissues at different stages between hepatocarcinogenesis group,non-hepatocarcinogenesis group,and control group(P〉0.05),but the expression levels of ERK1 and ERK2 mRNA in HCC tissues were higher than those in biopsy tissues before HCC development(P〈0.01) and up-regulated compared with para-HCC liver tissues,liver tissues in rats without hepatogenesis,and normal liver tissues in control rats(P〈0.05).Western blotting showed that the expression levels of p-ERK1 and p-ERK2 proteins in HCC tissues were higher than those in para-HCC tissues,liver tissues in rats without hepatogenesis,and biopsy tissues before HCC development(P〈0.01).Conclusion:The data show that the ERK1 and ERK2 signal transduction pathway is in relatively normal condition before HCC development,and ERK1 and ERK2 signaling transduction pathway is abnormally activated in the progression stage of HCC.The results indicate that the ERK1/2 signaling transduction pathway is involved in the initiation and progression of HCC.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第8期707-710,共4页 Tumor
基金 李嘉诚基金会西部教育计划赠款项目[编号:教外港(2001)33] 广西留学回国人员科研基金资助项目(编号:桂科回0236007)
关键词 肝细胞 蛋白激酶类 信号转导 动物实验 大鼠 Carcinoma hepatocellular Protein kinases Signal transduction Animal experimentation Rats
  • 相关文献

参考文献14

  • 1DAVIS R J. The mitogen-activated protein kinase signal transduction pathway [ J ]. J Biol Chem, 1993,268 ( 20 ) : 14553-14556.
  • 2BOULTON T G, NYE S H, ROBBINS D J, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF[ J]. Cell, 1991,65 (4) :663-675.
  • 3冯德云,郑晖,蒋海鹰,谭怡,程瑞雪.肝细胞癌及其癌旁肝组织中MAPK磷酸化与c-fos和c-jun蛋白表达的关系[J].临床与实验病理学杂志,2000,16(6):441-443. 被引量:3
  • 4HUYNH H, NGUYEN TT, CHOW KH, et al. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)- MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis [ J ]. BMC Gastroenterol,2003,3 : 19.
  • 5SANTEN R J, SONG RX, McPHERSON R, et al. The role of mitogen-activated protein (MAP) kinase in breast cancer [ J]. J Steroid Biochem Mol Biol,2002,80 (2) :239-256.
  • 6COUTTS A S , MURPHY L C. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells [ J ]. Cancer Res, 1998,58 ( 18 ) :4071-4074.
  • 7关剑,李柏林,宋敏,李凤,张英,宋继谒.乳腺浸润性导管癌组织学分级与BAD、p-BAD及p-ERK蛋白的表达[J].肿瘤,2006,26(3):267-270. 被引量:2
  • 8DAVIDO D J, RICHTER F, BOXBERGER F, et al. Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation[ J]. Eur J Cancer Prey,2001, 10(4) :313-321.
  • 9GIOELI D, MANDELL J W, PETRONI G R, et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression [ J ]. Cancer Res, 1999,59 ( 2 ) :279-84.
  • 10张立春,李凯,佟咸利,罗晓冬,王平,陈耀.ERK在前列腺癌及增生组织中的表达及其意义[J].中国医科大学学报,2003,32(1):56-57. 被引量:4

二级参考文献27

  • 1严瑞琪,苏建家.人乙型肝炎病毒和黄曲霉毒素B1诱发树qu原发性肝癌的研究[J].中华病理学杂志,1989,18(1):19-21. 被引量:18
  • 2[1]Ahn NG, Seger R, Krebs EG. The mitogen-activated protein kinase activator[J]. Gurr opin Cell Biol, 1992,4(6):992-995.
  • 3[2]Giocli D.Mandell JW , Petroni GR,et al.Activation of mitogen-activated protein kinase associated with prostate cancer progression[J].J Cancer Res, 1999,59(2):279-284.
  • 4[3]Treisman R.Regulation of transcription by MAPK cascades[J]. Curr Op Cell Biol, 1996,8(2):205-215.
  • 5[4]Mar Royuela. Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate[J]. Human Pathol, 2002,33(2):207-215 .
  • 6[5]Davis R J. The mitogen-activated protein kinase signal transduction pathway[J]. Biol Chem, 1993,268(5):14553-14558.
  • 7[6]Magi-Galluzzi C,Tawfic S,Ahmed K, et al. MKP-1 is overexpressed in prostate cancers and is inversely related to apoptosis[J]. Lab Invest, 1997,76(1):37-54.
  • 8Jain N,Oncogene,1998年,17卷,24期,3157页
  • 9LIPPONEN P,ALTOMAA S,KOSMA VM, et al. Apoptosis in breast cancer as related to histopathologieal characteristics and prognosis[J]. Fur J Cancer , 1994,14:2068-2073.
  • 10BERARDO M D, ELLEDGE R M, de MOOR C, et al . bel-2 and apoptosis in lymph node positive breast eareinoma [J].Cancer , 1998,82 : 1296-1302.

共引文献14

同被引文献33

  • 1段小娴,苏建家,汪芸,李瑗,欧超,杨春,曹骥,岳惠芬.银杏叶对二乙基亚硝胺诱导的肝癌作用研究[J].中国肿瘤,2006,15(8):544-546. 被引量:8
  • 2KENSLER T W, EGNER P A, WANG J B, et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas [ J ]. Gastroenterology,2004,127 (5 Suppl 1 ) : S310-S318.
  • 3PINEAU P, MARCHIO A, BATTISTON C, et al. Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure [ J]. Mutat Res ,2008,653(1/2) :6-13.
  • 4JOHNSON D N, EGNER P A, OBRIAN G, et al. Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry [ J ]. Chem Res Toxicol,2008,21 (3) :752-760.
  • 5SIMONICH M T, EGNER P A, ROEBUCK B D, et al. Natural chlorophyll inhibits aflatoxin Bl-induced multi-organ carcinogenesis in the rat [ J ]. Carcinogenesis, 2007, 28 (6) : 1294-1302.
  • 6TANG L, GUAN H, DING X, et al. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats [ J ]. Toxicol Appl Pharmacol,2007,219( 1 ) : 10-17.
  • 7KAMDEM L K, MEINEKE I, GODTEL-ARMBRUST U, et al. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1 [ J ]. Chem Res Toxicol,2006,19 ( 4 ) : 577- 586.
  • 8PRIMIANO T, EGNER P A, SUTTFER T R, et al. Intermittent dosing with oltipraz : relationship between chemoprevention of ariatoxin-induced tumorigenesis and induction of glutathione S-transferases [J]. Cancer Res,1995,55(19) :4319-4324.
  • 9SHEN H M, ONG C N, SHI C Y. Involvement of reactive oxygen species in aflatoxin Bl-induced cell injury in cultured rat hepatocytes [ J]. Toxicology, 1995,99 (1/2) : 115-123.
  • 10MUKHERJEE B, DAS T, GHOSH S, et al. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf. 1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats [ J]. Eur J Cancer Prey,2007,16(4) :363-371.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部